More than clinical success.
Higher predictability.

Patients’ expectations of esthetic outcomes and shortened treatment duration represent a significant challenge for practitioners. SLActive® is designed to provide higher treatment predictability even in challenging protocols helping to reduce the overall treatment complexity and improve patient acceptance.10 – 15

Improve less invasive prodecures

The Roxolid® material is designed to reduce the invasiveness of procedures with smaller implant diameters thanks to improved mechanical and biological properties. Predictability can be further improved by enhancing the bone formation and stability around the implant. SLActive® supports less invasive procedures with narrower implants in the anterior and premolar regions by enhancing the bone stability and the success rate as shown in a randomized controlled clinical study.10

Promotion of bone regeneration in bone defects

Bone defects such as bone dehiscences, fenestrations or coronal circumferential defects can compromise the predictability of osseointegration. SLActive® promotes the production of significantly greater and more mature bone than hydrophobic surfaces, and it increases new bone height, bone fill and BIC.4, 11, 12

High stability in early implant placement post-extraction

The timing of implant placement post-extraction in the esthetic zone is considered to be an important success factor. Ridge changes after tooth extraction occur from bone resorption and often result in a crater-like bone defect on the facial aspect of the extraction site. SLActive® demonstrates long-term stability of peri-implant hard and soft tissues after 6 years with highly esthetic outcomes in early implant placement.13, 14

High success rate in immediate and early loading

During the healing phase, a prosthetic restoration can be placed. However, uncontrolled loading on a healing implant increases the risk of early failures. SLActive® has shown more predictability in early loading protocols. Immediate and early loading with the SLActive® surface yield excellent long-term results with survival and success rates of 96.8 % after 5 years, even in poor bone quality.15


4 Schwarz, F., et al., Bone regeneration in dehiscence-type defects at non-submerged and submerged chemically modified (SLActive®) and conventional SLA® titanium implants: an immunohistochemical study in dogs. J Clin.Periodontol. 35.1 (2008): 64–75. 10 Benic GI, Gallucci GO, Mokti M, Hämmerle CH, Weber HP, Jung RE. Titanium-zirconium narrow-diameter versus titanium regular-diameter implants for anterior and premolar single crowns: 1-year results of a randomized controlled clinical study. Journal of Clinical Periodontology 2013; [Epub ahead of print] 11 Schwarz, F., et al., Bone regeneration in dehiscence-type defects at chemically modified (SLActive®) and conventional SLA® titanium implants: a pilot study in dogs. J Clin.Periodontol. 34.1 (2007): 78–86 12 Lai HC, Zhuang LF, Zhang ZY, Wieland M, Liu X. Bone apposition around two different sandblasted, large-grit and acid-etched implant surfaces at sites with coronal circumferential defects: An experimental study in dogs. Clin. Oral Impl. Res. 2009;20(3):247–53. 13 Buser D, Wittneben J, Bornstein MM, Grütter L, Chappuis V, Belser UC. Stability of Contour Augmentation and Esthetic Outcomes of Implant-Supported Single Crowns in the Esthetic Zone: 3-Year Result of a Prospective Study With Early Implant Placement Post Extraction. J Periodontol. 2011 March; 82(3): 342-9. 14 Buser D, Chappuis V, Kuchler U, Bornstein MM, Wittneben JG, Buser R, Cavusoglu Y, Belser UC. Long-term Stability of Early Implant Placement with Contour Augmentation. J Dent Res. 2013 Dec;92(12 Suppl):176S-82S. 15 Nicolau P, Reis R, Guerra F, Rocha S, Tondela J, Brägger U. Immediate and early loading of Straumann® SLActive implants: A Five Year Follow-up. Presented at the 19th Annual Scientific Meeting of the European Association of Osseointegration – 6-9 October 2010, Glasgow.